{
    "title": "Drug Discovery under Covariate Shift with Domain-Informed Prior Distributions over Functions. (arXiv:2307.15073v1 [q-bio.BM])",
    "abstract": "Accelerating the discovery of novel and more effective therapeutics is an important pharmaceutical problem in which deep learning is playing an increasingly significant role. However, real-world drug discovery tasks are often characterized by a scarcity of labeled data and significant covariate shift$\\unicode{x2013}\\unicode{x2013}$a setting that poses a challenge to standard deep learning methods. In this paper, we present Q-SAVI, a probabilistic model able to address these challenges by encoding explicit prior knowledge of the data-generating process into a prior distribution over functions, presenting researchers with a transparent and probabilistically principled way to encode data-driven modeling preferences. Building on a novel, gold-standard bioactivity dataset that facilitates a meaningful comparison of models in an extrapolative regime, we explore different approaches to induce data shift and construct a challenging evaluation setup. We then demonstrate that using Q-SAVI to int",
    "link": "http://arxiv.org/abs/2307.15073",
    "context": "Title: Drug Discovery under Covariate Shift with Domain-Informed Prior Distributions over Functions. (arXiv:2307.15073v1 [q-bio.BM])\nAbstract: Accelerating the discovery of novel and more effective therapeutics is an important pharmaceutical problem in which deep learning is playing an increasingly significant role. However, real-world drug discovery tasks are often characterized by a scarcity of labeled data and significant covariate shift$\\unicode{x2013}\\unicode{x2013}$a setting that poses a challenge to standard deep learning methods. In this paper, we present Q-SAVI, a probabilistic model able to address these challenges by encoding explicit prior knowledge of the data-generating process into a prior distribution over functions, presenting researchers with a transparent and probabilistically principled way to encode data-driven modeling preferences. Building on a novel, gold-standard bioactivity dataset that facilitates a meaningful comparison of models in an extrapolative regime, we explore different approaches to induce data shift and construct a challenging evaluation setup. We then demonstrate that using Q-SAVI to int",
    "path": "papers/23/07/2307.15073.json",
    "total_tokens": 917,
    "translated_title": "在特征转移条件下利用基于领域信息的先验分布进行药物发现",
    "translated_abstract": "加速发现新型和更有效的治疗药物是一个重要的制药问题，深度学习在其中扮演着愈发重要的角色。然而，真实世界的药物发现任务通常特点是标签数据稀缺和显著的特征转移，这对于标准的深度学习方法构成了挑战。在本论文中，我们提出了Q-SAVI，这是一个概率模型，能够通过将数据生成过程的显式先验知识编码为函数的先验分布，为研究人员提供了一种透明且概率上合理的方式来编码数据驱动的建模偏好。基于一个新颖的，高标准的生物活性数据集，使得在外推模式下能够进行有意义的模型比较，我们探索了不同的方法来诱导数据转移并构建一个具有挑战性的评估环境。然后我们证明了使用Q-SAVI可以在特征转移条件下更好地进行药物发现。",
    "tldr": "这篇论文提出了一种基于领域信息的先验分布模型Q-SAVI，能够解决药物发现中标签数据稀缺和特征转移的问题，并提供了一种透明且概率上合理的数据驱动模型建模方式。",
    "en_tdlr": "This paper proposes a prior distribution model called Q-SAVI, which uses domain-informed prior distributions to address the challenges of scarce labeled data and covariate shift in drug discovery, providing a transparent and probabilistically principled way for data-driven modeling."
}